Sec Form 4 Filing - PETKANAS DEAN @ NEUROPATHIX, INC. - 2022-01-05

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person PETKANAS DEAN 2. Issuer Name and Ticker or Trading Symbol NEUROPATHIX, INC. [ NPTX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) 3805 OLD EASTON ROAD 3. Date of Earliest Transaction (MM/DD/YY) 01/05/2022 (Street) DOYLESTOWN, PA18902 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 01/05/2022 S( 1 ) 89,000 D $ 0.047( 2 )( 3 ) 24,770,029 I See Note( 4 ) Common Stock 01/06/2022 S( 1 ) 120,000 D $ 0.051( 2 )( 5 ) 24,650,029 I See Note( 4 ) Common Stock 01/07/2022 S( 1 ) 41,000 D $ 0.046 24,609,029 I See Note( 4 ) Common Stock 01/07/2022 G( 6 ) 300,000 D $ 0 24,309,029 I See Note( 4 ) Common Stock 01/07/2022 G( 6 ) 250,000 D $ 0 24,059,029 I See Note( 4 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other PETKANAS DEAN 3805 OLD EASTON ROAD DOYLESTOWN, PA18902 X X Chief Executive Officer Signatures /s/ Dean Petkanas 01/07/2022 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person. ( 2 )These shares were sold in multiple transactions at prices falling within those ranges set forth in footnotes (3) and (5) of this Form 4. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the relevant footnotes. ( 3 )These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive. ( 4 )These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive. ( 5 )Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein. ( 6 )Represents a gift of shares by Golden Gate Capital Partners, LLC.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.